| (Senior) Market Access Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Market Access |
Nov 12, 2024 |
| Sr. Sales Executive-BC |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Nov 10, 2024 |
| (Sr.) Sales Executive-Solid Tumor |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Nov 04, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| Key Account Executive |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Okt 28, 2024 |
| (Senior) Medical Advisor (Radioligand Therapy) |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Research & Development |
Okt 09, 2024 |
| Associate Sales Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Jul 18, 2024 |
| (Sr.) Sales Executive-OPH |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Innovative Medicines |
Der Umsatz |
Jun 12, 2024 |